Interleukin-1 receptor antagonist enhances chemosensitivity to fluorouracil in treatment of Kras mutant colon cancer.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY(2020)
摘要
BACKGROUND Kras mutant colon cancer shows abnormal activation of the nuclear factor kappa-B (NF-kappa B) pathway, resulting in the proliferation of tumor cells. Treatment with fluorouracil (5-FU) might not achieve the expected inhibition of proliferation of malignant cells based on the fluorouracil-induced activation of the NF-kappa B pathway. AIM To detect whether interleukin (IL)-1 receptor antagonist (IL-1RA) could increase the chemosensitivity to 5-FU by decreasing the activation of the NF-kappa B pathway and reducing the proliferation of colon cancer cells. METHODS Western blot analysis was performed to detect the persistent activation of the NF-kappa B pathway in colon cancer cell lines. Reverse transcription-polymerase chain reaction was used to detect the IL-1RA-reduced expression levels of IL-6, IL-8, IL-17, IL-21 and TLR4 in colon cancer cell lines. We used a xenograft nude mouse model to demonstrate the downregulation of the NF-kappa B pathway by blocking the NF-kappa B-regulated IL-1 alpha feedforward loop, which could increase the efficacy of chemotherapeutic agents in inhibiting tumor cell growth. RESULTS IL-1 receptor antagonist could decrease the expression of IL-1 alpha and IL-1 beta and downregulate the activity of the NF-kappa B pathway in Kras mutant colon cancer cells. Treatment with 5-FU combined with IL-1RA could increase the chemosensitivity of the SW620 cell line, and decreased expression of the TAK1/NF-kappa B and MEK pathways resulted in limited proliferation in the SW620 cell line. CONCLUSION Adjuvant chemotherapy with IL-1RA and 5-FU has a stronger effect than single chemotherapeutic drugs. IL-1RA combined with fluorouracil could be a potential neoadjuvant chemotherapy in the clinic.
更多查看译文
关键词
Colon carcinoma,Chemotherapy,Nuclear factor kappa-B,Interleukin-1,Proliferation,Fluorouracil
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要